$PEB
Pebblebrook Hotel Trust Stock $peb

$peb Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000147409823000133 Filed on July 27, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$395.8M	$384.3M
YoY Change	-5.01%	-3.32%
Cost Of Revenue	$249.8M	$246.0M
YoY Change	-0.7%	7.72%
Gross Profit	$146.0M	$138.3M
YoY Change	-11.58%	-18.22%
Gross Profit Margin	36.9%	35.99%
Selling, General & Admin	$44.45M	$40.77M
YoY Change	-1.04%	-4.53%
% of Gross Profit	30.44%	29.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$63.27M	$57.96M
YoY Change	4.8%	-3.84%
% of Gross Profit	43.32%	41.9%
Operating Expenses	$107.7M	$98.73M
YoY Change	2.31%	-4.13%
Operating Profit	-$26.04M	$39.58M
YoY Change	-149.87%	-23.79%
Interest Expense	$31.02M	-$29.54M
YoY Change	23.99%	-227.56%
% of Operating Profit		-74.64%
Other Income/Expense, Net	$1.403M	$952.0K
YoY Change	1040.65%	6700.0%
Pretax Income	-$55.66M	$46.21M
YoY Change	-303.74%	60.48%
Income Tax	$822.0K	$31.00K
% Of Pretax Income		0.07%
Net Earnings	-$57.14M	$33.45M
YoY Change	-327.95%	19.52%
Net Earnings / Revenue	-14.44%	8.7%
Basic Earnings Per Share	-$0.57	$0.27
Diluted Earnings Per Share	-$0.57	$0.22
COMMON SHARES
Basic Shares Outstanding	120.5M shares	123.1M shares
Diluted Shares Outstanding	120.1M shares	151.2M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$182.7M	$175.6M
YoY Change	-4.24%	447.81%
Cash & Equivalents	$182.7M	$175.6M
Short-Term Investments
Other Short-Term Assets	$131.8M	$121.2M
YoY Change	39.2%	42.64%
Inventory
Prepaid Expenses
Receivables	$56.84M	$51.58M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$371.3M	$348.3M
YoY Change	5.43%	102.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.553B	$5.714B
YoY Change	-6.9%	-5.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$74.40M	$10.74M
YoY Change	284.07%	-93.95%
Total Long-Term Assets	$5.628B	$5.725B
YoY Change	-5.96%	-7.91%
TOTAL ASSETS
Total Short-Term Assets	$371.3M	$348.3M
Total Long-Term Assets	$5.628B	$5.725B
Total Assets	$5.999B	$6.073B
YoY Change	-5.33%	-4.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$272.7M	$215.5M
YoY Change	15.77%	-1.52%
Accrued Expenses	$288.6M	$328.6M
YoY Change	-12.74%	1.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$648.1M	$637.5M
YoY Change	-0.56%	0.95%
LONG-TERM LIABILITIES
Long-Term Debt	$2.410B	$2.432B
YoY Change	-2.1%	-5.01%
Other Long-Term Liabilities	$1.647M	$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$2.411B	$2.432B
YoY Change	-2.03%	-5.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$648.1M	$637.5M
Total Long-Term Liabilities	$2.411B	$2.432B
Total Liabilities	$3.059B	$3.159B
YoY Change	-1.72%	-1.17%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.201M	$1.201M
YoY Change	-8.25%	-8.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.849B	$2.914B
YoY Change
Total Liabilities & Shareholders Equity	$5.999B	$6.073B
YoY Change	-5.33%	-4.94%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$57.14M	$33.45M
YoY Change	-327.95%	19.52%
Depreciation, Depletion And Amortization	$63.27M	$57.96M
YoY Change	4.8%	-3.84%
Cash From Operating Activities	$82.06M	$73.99M
YoY Change	-26.59%	-28.71%
INVESTING ACTIVITIES
Capital Expenditures	$39.62M	$65.37M
YoY Change	-253.1%	-389.98%
Acquisitions
YoY Change
Other Investing Activities	$559.0K	$95.53M
YoY Change	-99.68%	-154.84%
Cash From Investing Activities	-$39.06M	$30.16M
YoY Change	-126.03%	-115.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-37.68M	-64.41M
YoY Change	-67.1%	-207.75%
NET CHANGE
Cash From Operating Activities	82.06M	73.99M
Cash From Investing Activities	-39.06M	30.16M
Cash From Financing Activities	-37.68M	-64.41M
Net Change In Cash	5.320M	39.74M
YoY Change	-96.39%	-219.84%
FREE CASH FLOW
Cash From Operating Activities	$82.06M	$73.99M
Capital Expenditures	$39.62M	$65.37M
Free Cash Flow	$42.44M	$8.621M
YoY Change	-69.17%	-93.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	peb	Sale Of Real Estate Held For Sale Number Of Properties SaleOfRealEstateHeldForSaleNumberOfProperties	2	property
	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	97000000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2023Q2	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0392549
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	28600000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	28600000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120057744	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120057744	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126345293	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126345293	shares
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50008000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3032000	usd
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1237000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	12151000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	21120000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	6938000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	46183000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3004112000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3084934000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-75000	usd
CY2022Q2	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	78000000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2620000	usd
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1344000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	11990000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	9330000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2404000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	28797000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3192676000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3084543000	usd
	peb	Share Value Issued For Board Of Trustees Compensation ShareValueIssuedForBoardOfTrusteesCompensation	754000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	92753000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5911000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	2489000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24303000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	21074000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	12763000	usd
	us-gaap	Profit Loss ProfitLoss	24138000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3004112000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3163905000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-75000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	78000000	usd
	peb	Share Value Issued For Board Of Trustees Compensation ShareValueIssuedForBoardOfTrusteesCompensation	738000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1113000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4974000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	2475000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	23334000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	36697000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-6778000	usd
	us-gaap	Profit Loss ProfitLoss	-71419000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3192676000	usd
	us-gaap	Profit Loss ProfitLoss	24138000	usd
	us-gaap	Profit Loss ProfitLoss	-71419000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	116326000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	119374000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5911000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4974000	usd
	peb	Amortization Of Debt Issuance Costs Non Cash Interest And Other Amortization AmortizationOfDebtIssuanceCostsNonCashInterestAndOtherAmortization	5874000	usd
	peb	Amortization Of Debt Issuance Costs Non Cash Interest And Other Amortization AmortizationOfDebtIssuanceCostsNonCashInterestAndOtherAmortization	6852000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	30219000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	73254000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4951000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4978000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6186000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2945000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6181000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19048000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12542000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12328000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7654000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	34779000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10496000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4158000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	120222000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	142629000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	97674000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	42411000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	224384000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	72969000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	247163000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	11388000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2760000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	86000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	135338000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-216691000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	994000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	27111000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	92753000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1113000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2541000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2644000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	24303000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	22688000	usd
	peb	Repayments Of Membership Deposits RepaymentsOfMembershipDeposits	649000	usd
	peb	Repayments Of Membership Deposits RepaymentsOfMembershipDeposits	1668000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-121538000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44605000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	134022000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29457000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52269000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92247000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186291000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62790000	usd
CY2023Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	47	property
CY2023Q2	peb	Number Of Guest Rooms NumberOfGuestRooms	12142	hotelroom
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management’s best judgment, after considering past, current and expected events and economic conditions. Actual results could differ from these estimates.</span></div>
	peb	Sale Of Real Estate Held For Investment Consideration Received SaleOfRealEstateHeldForInvestmentConsiderationReceived	232250000	usd
CY2022	peb	Sale Of Real Estate Held For Investment Consideration Received SaleOfRealEstateHeldForInvestmentConsiderationReceived	77000000	usd
CY2023Q2	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	-400000	usd
	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	-700000	usd
CY2022Q2	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	1200000	usd
	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	-3700000	usd
CY2023Q2	us-gaap	Land Land	860270000	usd
CY2022Q4	us-gaap	Land Land	897756000	usd
CY2023Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	5099194000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	5170976000	usd
CY2023Q2	peb	Furniture Fixtures And Equipment FurnitureFixturesAndEquipment	509555000	usd
CY2022Q4	peb	Furniture Fixtures And Equipment FurnitureFixturesAndEquipment	504518000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	91181000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	91181000	usd
CY2023Q2	us-gaap	Development In Process DevelopmentInProcess	21675000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	11961000	usd
CY2023Q2	peb	Real Estate Investment Property Excluding Operating Lease Right Of Use Asset At Cost RealEstateInvestmentPropertyExcludingOperatingLeaseRightOfUseAssetAtCost	6581875000	usd
CY2022Q4	peb	Real Estate Investment Property Excluding Operating Lease Right Of Use Asset At Cost RealEstateInvestmentPropertyExcludingOperatingLeaseRightOfUseAssetAtCost	6676392000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	365570000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	370383000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6947445000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	7046775000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1233129000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1171899000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	5714316000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	5874876000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	73300000	usd
	peb	Impairment Of Real Estate Number Of Properties ImpairmentOfRealEstateNumberOfProperties	2	property
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	320500000	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	43000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	320400000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	42700000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2400985000	usd
CY2022Q4	peb	Debt Instrument Unamortized Discount Premium Net And Deferred Financing Costs Net DebtInstrumentUnamortizedDiscountPremiumNetAndDeferredFinancingCostsNet	13692000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2387293000	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	12600000	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	12600000	usd
	peb	Debt Instrument Election Period Prior To Maturity Date DebtInstrumentElectionPeriodPriorToMaturityDate	P2D
CY2023Q2	peb	Debt Instrument Redemption Price To Principal Amount Percentage DebtInstrumentRedemptionPriceToPrincipalAmountPercentage	1
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1880000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2164000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3731000	usd
CY2023Q2	peb	Interest Expense Debt Other InterestExpenseDebtOther	1065000	usd
CY2022Q2	peb	Interest Expense Debt Other InterestExpenseDebtOther	612000	usd
	peb	Interest Expense Debt Other InterestExpenseDebtOther	2120000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	29544000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	23161000	usd
	us-gaap	Interest Expense InterestExpense	56974000	usd
CY2023Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	400000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	384343000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	397524000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	28600000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	28600000	shares
CY2023Q2	peb	Common Unit Redemption Rights Redemption Option Common Share Conversion Basis CommonUnitRedemptionRightsRedemptionOptionCommonShareConversionBasis	1	shares
CY2023Q2	peb	Long Term Incentive Partnership Units Outstanding LongTermIncentivePartnershipUnitsOutstanding	858484	shares
CY2022Q4	peb	Long Term Incentive Partnership Units Outstanding LongTermIncentivePartnershipUnitsOutstanding	727208	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1498820	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151238955	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160720239	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	123581926	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130904589	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q2	peb	Long Term Incentive Partnership Units Outstanding LongTermIncentivePartnershipUnitsOutstanding	858484	shares
CY2022Q4	peb	Long Term Incentive Partnership Units Outstanding LongTermIncentivePartnershipUnitsOutstanding	727208	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33738000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16646000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-178000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-94228000	usd
CY2023Q2	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	10000	usd
CY2022Q2	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	12000	usd
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	21000	usd
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	22000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	276000	usd
CY2022Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	133000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2023Q2	peb	Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings	33452000	usd
CY2022Q2	peb	Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings	16501000	usd
	peb	Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings	-199000	usd
	peb	Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings	-94250000	usd
CY2023Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3281000	usd
CY2022Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3281000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	36733000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19782000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-199000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-94250000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	121696400	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130904876	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123581926	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130904589	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	101380	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	374188	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	29441175	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	29441175	shares
CY2023Q2	peb	Combined Base And Incentive Management Fee Expense Reversal CombinedBaseAndIncentiveManagementFeeExpenseReversal	10800000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	peb	Accrued Additions And Improvements To Hotel Properties AccruedAdditionsAndImprovementsToHotelProperties	8695000	usd
	peb	Accrued Additions And Improvements To Hotel Properties AccruedAdditionsAndImprovementsToHotelProperties	6762000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1005000	usd
	peb	Write Off Of Fully Amortized Debt Issuance Costs WriteOffOfFullyAmortizedDebtIssuanceCosts	64000	usd
	peb	Write Off Of Fully Amortized Debt Issuance Costs WriteOffOfFullyAmortizedDebtIssuanceCosts	5723000	usd
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	peb	Combined Base And Incentive Management Fee Expense Reversal CombinedBaseAndIncentiveManagementFeeExpenseReversal	18800000	usd
CY2022Q2	peb	Combined Base And Incentive Management Fee Expense Reversal CombinedBaseAndIncentiveManagementFeeExpenseReversal	12100000	usd
	peb	Combined Base And Incentive Management Fee Expense Reversal CombinedBaseAndIncentiveManagementFeeExpenseReversal	19800000	usd
	peb	Reserve Funds As Percentage Of Hotel Revenues ReserveFundsAsPercentageOfHotelRevenues	0.040
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10700000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11200000	usd
CY2023Q2	peb	Fixed Lease Cost FixedLeaseCost	4782000	usd
CY2022Q2	peb	Fixed Lease Cost FixedLeaseCost	4561000	usd
	peb	Fixed Lease Cost FixedLeaseCost	9564000	usd
	peb	Fixed Lease Cost FixedLeaseCost	9017000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5252000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5414000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	9119000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	8468000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	10034000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	9975000	usd
	us-gaap	Lease Cost LeaseCost	18683000	usd
	us-gaap	Lease Cost LeaseCost	17485000	usd
	us-gaap	Interest Paid Net InterestPaidNet	48852000	usd
	us-gaap	Interest Paid Net InterestPaidNet	41161000	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	0	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1434000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2723000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-536000	usd
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001474098-23-000133-index-headers.html	Edgar Link	pending
0001474098-23-000133-index.html	Edgar Link	pending
0001474098-23-000133.txt	Edgar Link	pending
0001474098-23-000133-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
peb-20230630.htm	Edgar Link	pending
peb-20230630.xsd	Edgar Link	pending
peb-20230630ex311.htm	Edgar Link	pending
peb-20230630ex312.htm	Edgar Link	pending
peb-20230630ex321.htm	Edgar Link	pending
peb-20230630ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
peb-20230630_cal.xml	Edgar Link	unprocessable
peb-20230630_def.xml	Edgar Link	unprocessable
peb-20230630_lab.xml	Edgar Link	unprocessable
peb-20230630_pre.xml	Edgar Link	unprocessable
peb-20230630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PEB
Pebblebrook Hotel Trust Stock $peb

2023 Q3 Form 10-Q Financial Statement

#000147409823000133 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEB Pebblebrook Hotel Trust Stock $peb

2023 Q3 Form 10-Q Financial Statement

#000147409823000133 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEB
Pebblebrook Hotel Trust Stock $peb